Alongi F - Search Results

1

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without ²²³Ra.

Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G. Caffo O, et al. Among authors: alongi p, alongi f. Cancer Biother Radiopharm. 2021 Jun;36(5):391-396. doi: 10.1089/cbr.2020.4442. Epub 2021 Mar 25. Cancer Biother Radiopharm. 2021. PMID: 33769088

2

[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months.

Alongi F, Schipani S, Samanes Gajate AM, Rosso A, Cozzarini C, Fiorino C, Alongi P, Picchio M, Gianolli L, Messa C, Di Muzio N. Alongi F, et al. Among authors: alongi p. Tumori. 2010 Jul-Aug;96(4):613-7. doi: 10.1177/030089161009600416. Tumori. 2010. PMID: 20968143

3

Megavoltage CT images of helical tomotherapy unit for radiation treatment simulation: impact on feasibility of treatment planning in a prostate cancer patient with bilateral femoral prostheses.

Alongi F, Fodor A, Maggio A, Cozzarini C, Fiorino C, Broggi S, Alongi P, Calandrino R, Muzio ND. Alongi F, et al. Among authors: alongi p. Tumori. 2011 Mar-Apr;97(2):221-4. doi: 10.1177/030089161109700215. Tumori. 2011. PMID: 21617719 Review.

4

Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy.

Alongi F, Fersino S, Giaj Levra N, Mazzola R, Ricchetti F, Fiorentino A, Ruggieri R, Malfatti V, Cavalleri S, Salgarello M. Alongi F, et al. Clin Nucl Med. 2015 Nov;40(11):e496-500. doi: 10.1097/RLU.0000000000000841. Clin Nucl Med. 2015. PMID: 26053712

5

18F-Sodium Fluoride PET-CT for the Assessment of Brain Metastasis from Lung Adenocarcinoma.

Gori S, Inno A, Lunardi G, Gorgoni G, Malfatti V, Severi F, Alongi F, Carbognin G, Romano L, Pasetto S, Salgarello M. Gori S, et al. Among authors: alongi f. J Thorac Oncol. 2015 Aug;10(8):e67-8. doi: 10.1097/JTO.0000000000000523. J Thorac Oncol. 2015. PMID: 26200280 Free article. No abstract available.

6

Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.

Inno A, Bogina G, Turazza M, Bortesi L, Duranti S, Massocco A, Zamboni G, Carbognin G, Alongi F, Salgarello M, Gori S. Inno A, et al. Among authors: alongi f. Oncologist. 2016 Jan;21(1):28-32. doi: 10.1634/theoncologist.2015-0309. Epub 2015 Dec 9. Oncologist. 2016. PMID: 26659223 Free PMC article. Review.

7

Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.

Alongi F, Fersino S, Mazzola R, Fiorentino A, Giaj-Levra N, Ricchetti F, Ruggieri R, Di Paola G, Cirillo M, Gori S, Salgarello M, Zamboni G, Ruffo G. Alongi F, et al. Clin Transl Oncol. 2017 Feb;19(2):189-196. doi: 10.1007/s12094-016-1522-0. Epub 2016 Jun 7. Clin Transl Oncol. 2017. PMID: 27271749

8

Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43: A Step Forward in the Era of Functional Imaging?

Alongi F, Mazzola R, Aiello D, Salgarello M. Alongi F, et al. Eur Urol. 2017 Apr;71(4):e121-e122. doi: 10.1016/j.eururo.2016.10.050. Epub 2016 Nov 18. Eur Urol. 2017. PMID: 27876168 No abstract available.

9

Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by ¹⁸FDG-PET/CT.

Mazzola R, Fiorentino A, Di Paola G, Giaj Levra N, Ricchetti F, Fersino S, Tebano U, Pasetto S, Ruggieri R, Salgarello M, Alongi F. Mazzola R, et al. Among authors: alongi f. J Thorac Oncol. 2017 Mar;12(3):547-555. doi: 10.1016/j.jtho.2016.11.2234. Epub 2017 Jan 24. J Thorac Oncol. 2017. PMID: 28126325 Free article.

10

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study.

Triggiani L, Alongi F, Buglione M, Detti B, Santoni R, Bruni A, Maranzano E, Lohr F, D'Angelillo R, Magli A, Bonetta A, Mazzola R, Pasinetti N, Francolini G, Ingrosso G, Trippa F, Fersino S, Borghetti P, Ghirardelli P, Magrini SM. Triggiani L, et al. Among authors: alongi f. Br J Cancer. 2017 Jun 6;116(12):1520-1525. doi: 10.1038/bjc.2017.103. Epub 2017 Apr 27. Br J Cancer. 2017. PMID: 28449007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters